FrancophonIA/DGT-Translation_Memory huggingface dataset:
English: A 42-day randomised, controlled and double-blinded crossover study to evaluate effects of daily WSTC consumption on platelet function, coagulation and some baseline CVD risk markers.
French: Étude de 42 jours, randomisée et contrôlée en double aveugle, visant à évaluer les effets de la consommation journalière de WSTC sur la fonction plaquettaire, la coagulation et certains marqueurs de risque de référence des maladies cardio-vasculaires.
Italian: «A 42-day randomised, controlled and double-blinded crossover study to evaluate effects of daily WSTC consumption on platelet function, coagulation and some baseline CVD risk markers».
Portuguese: «A 42-day randomised, controlled and double-blinded crossover study to evaluate effects of daily WSTC consumption on platelet function, coagulation and some baseline CVD risk markers».
Greek: Τυχαιοποιημένη, ελεγχόμενη, διπλά τυφλή, κλινική μελέτη διασταυρούμενων ομάδων, διάρκειας 42 ημερών, για την αξιολόγηση της επίδρασης της ημερήσιας κατανάλωσης WSTC στη λειτουργία των αιμοπεταλίων, στην πήξη του αίματος και σε ορισμένους βασικούς δείκτες κινδύνου για καρδιαγγειακές παθήσεις.
Hungarian: 42 napos, randomizált, kontrollált és kettősvak keresztezett („crossover”) vizsgálat a napi WSTC-fogyasztásnak a trombocitafunkcióra, a koagulációra és néhány alapvető CVD (kardiovaszkuláris betegségek) kockázatjelzőre gyakorolt hatásának értékeléséhez.
English: A pilot study to compare the antiplatelet effects of WSTC in healthy subjects, after consumption in two different food matrices.
French: Étude pilote comparant les effets antiplaquettaires du WSTC chez des sujets sains après consommation de deux matrices alimentaires différentes.
Italian: «A pilot study to compare the antiplatelet effects of WSTC in healthy subjects, after consumption in two different food matrices».
Portuguese: «A pilot study to compare the antiplatelet effects of WSTC in healthy subjects, after consumption in two different food matrices».
Greek: Πιλοτική μελέτη με σκοπό τη σύγκριση της επίδρασης του WSTC στα αιμοπετάλια σε υγιή άτομα, μετά την κατανάλωση δύο διαφορετικών μητρών τροφίμων.
Hungarian: Kísérleti vizsgálat, melynek segítségével összehasonlíthatók a WSTC trombocita-aggregációt gátló hatásai egészséges alanyok esetében, két különböző élelmiszermátrixban való fogyasztást követően.
English: A randomised, controlled and double-blinded crossover study to compare the antiplatelet effects of three different formats of WSTC in healthy humans.
French: Étude randomisée et contrôlée en double aveugle, visant à comparer les effets de trois formats différents de WSTC chez les personnes en bonne santé.
Italian: «A randomised, controlled and double-blinded crossover study to compare the antiplatelet effects of three different formats of WSTC in healthy humans».
Portuguese: «A randomised, controlled and double-blinded crossover study to compare the antiplatelet effects of three different formats of WSTC in healthy humans».
Greek: Τυχαιοποιημένη, ελεγχόμενη, διπλά τυφλή, κλινική μελέτη διασταυρούμενων ομάδων για τη σύγκριση της αντιαιμοπεταλιακής δράσης τριών διαφορετικών μορφών WSTC σε υγιή άτομα.
Hungarian: Randomizált, kontrollált, kettősvak keresztezett vizsgálat, melynek segítségével összehasonlíthatók három különböző WSTC-formátum trombocita-aggregációt gátló hatásai egészséges emberekben.
English: O’Kennedy, N., Crosbie, L., van Lieshout M., Broom J.I., Webb, D.J., Duttaroy, A.K., 2003a. Persistence of the antiplatelet effect of a single dose of WSTC equivalent to 2 fresh tomatoes over a 24-hour timecourse. REC No 02/0269
Spanish: O’ Kennedy, N.; Crosbie, L.; van Lieshout, M.; Broom, J.I..; Webb, D.J.; Duttaroy, A.K.: «Persistence of the antiplatelet effect of a single dose of WSTC equivalent to 2 fresh tomatoes over a 24-hour timecourse», REC No 02/0269, 2003a.
Swedish: O’Kennedy N, Crosbie L, van Lieshout M, Broom JI, Webb DJ, Duttaroy AK, 2003a, Persistence of the antiplatelet effect of a single dose of WSTC equivalent to 2 fresh tomatoes over a 24-hour timecourse, REC nr 02/0269.
English: O’Kennedy et al. 2003b. A 42-day randomised, controlled and double-blinded crossover study to evaluate effects of daily WSTC consumption on platelet function, coagulation and some baseline CVD risk markers. REC No 03/0177.
Spanish: O’ Kennedy y otros: «A 42-day randomised, controlled and double-blinded crossover study to evaluate effects of daily WSTC consumption on platelet function, coagulation and some baseline CVD risk markers», REC No 03/0177, 2003.
Swedish: O’Kennedy et al, 2003b, A 42-day randomised, controlled and double-blinded crossover study to evaluate effects of daily WSTC consumption on platelet function, coagulation and some baseline CVD risk markers, REC nr 03/0177.
English: O’Kennedy et al. 2005. Effects of overconsuming Sirco®, a one-a-day fruit juice drink containing 12g/L WSTC, on platelet function in healthy subjects. REC No 05/S0802/77.
Spanish: O’ Kennedy y otros: «Effects of overconsuming Sirco®, a one-a-day fruit juice drink containing 12g/L WSTC, on platelet function in healthy subjects», REC No 05/S0802/77, 2005.
Swedish: O’Kennedy et al, 2005, Effects of overconsuming Sirco®, a one-a-day fruit juice drink containing 12g/L WSTC, on platelet function in healthy subjects, REC nr 05/S0802/77.
English: O’Kennedy et al. 2006c. A pilot study to compare the antiplatelet effects of WSTC in healthy subjects, after consumption in two different food matrices. REC No 06/S0802/60.
Spanish: O’ Kennedy y otros: «A pilot study to compare the antiplatelet effects of WSTC in healthy subjects, after consumption in two different food matrices», REC No 06/S0802/60, 2006c.
Swedish: O’Kennedy et al, 2006c, A pilot study to compare the antiplatelet effects of WSTC in healthy subjects, after consumption in two different food matrices, REC nr 06/S0802/60.
English: O’Kennedy et al. 2007. A randomised, controlled and double-blinded crossover study to compare the antiplatelet effects of three different formats of WSTC in healthy humans. REC No 07/S0801/13.
Spanish: O’ Kennedy y otros: «A randomised, controlled and double-blinded crossover study to compare the antiplatelet effects of three different formats of WSTC in healthy humans», REC No 07/S0801/13, 2007.
Swedish: O’Kennedy et al, 2007, A randomised, controlled and double-blinded crossover study to compare the antiplatelet effects of three different formats of WSTC in healthy humans, REC nr 07/S0801/13.
English: Song, V., Sheddon, A., Horgan, G. and O’Kennedy, N. Anticoagulatory and anti-inflammatory activities of WSTC in platelets and endothelial cells. Manuscript for submission; 2008.
Spanish: Song, V,; Sheddon, A.; Horgan, G. y O’Kennedy, N.: «Anticoagulatory and anti-inflammatory activities of WSTC in platelets and endothelial cells», Manuscrito para presentación; 2008.
Swedish: Song V, Sheddon A, Horgan G och O’Kennedy N, Anticoagulatory and anti-inflammatory activities of WSTC in platelets and endothelial cells, Manuskript för inlämning, 2008.
English: This Decision is addressed to Provexis Natural Products Ltd, Thames Court, 1 Victoria Street, Windsor, Berkshire, SL4 1YB, United Kingdom .
French: Provexis Natural Products Ltd, Thames Court, 1 Victoria Street, Windsor, Berkshire, SL4 1YB, Royaume-Uni , est destinataire de la présente décision.
Italian: La Provexis Natural Products Ltd, Thames Court, 1 Victoria Street, Windsor, Berkshire, SL4 1YB, Regno Unito , è destinataria della presente decisione.
English: Persistence of the antiplatelet effect of a single dose of WSTC equivalent to 2 fresh tomatoes over a 24-hour timecourse. REC No 02/0269
French: Maintien de l’effet antiplaquettaire d’une simple dose de WSTC équivalent à 2 tomates fraîches sur une période de 24 h. REC no 02/0269
English: Following the receipt of the Authority’s opinion, the Commission went back to the applicant for further clarification on the justification provided regarding the nine studies claimed as proprietary and in particular regarding the ‘exclusive right of reference’ as referred to in Article 21(1)(b) of Regulation (EC) No 1924/2006. All the justifiable information provided by the applicant has been assessed. For the seven unpublished studies it is considered that the requirements laid down in Article 21(1) of Regulation (EC) No 1924/2006 are fulfilled.
Hungarian: A Hatóság véleményének kézhezvételét követően a Bizottság további pontosítást kért a kérelmezőtől a kilenc, állítólag védett tanulmánnyal kapcsolatos indokolást illetően, különös tekintettel az 1924/2006/EK rendelet 21. cikke (1) bekezdésének b) pontjában szereplő „kizárólagos hivatkozási jogra”.
English: Accordingly, the scientific data and other information included in the seven studies may not be used for the benefit of a subsequent applicant for a period of 5 years from the date of authorisation, under the conditions laid down in Article 21(1) of that Regulation. For the two studies, which had been published prior to the submission of the application for authorisation of the health claim [3], it is considered that as the studies have been published and made available to the public domain, their protection is not justified in the light of the objectives of Regulation (EC) No 1924/2006 among which to protect the investment made by innovators in gathering the information and data supporting an application under that Regulation and accordingly it should not be granted.
Hungarian: A kérelmező által szolgáltatott összes indokolható információt megvizsgálták.
English: Article 1 The health claim set out in the Annex to this Decision shall be included in the Community list of permitted claims as provided for in Article 13(3) of Regulation (EC) No 1924/2006. Article 2
Hungarian: A kérelmező által a Bizottság számára az 1924/2006/EK rendelet 16. cikkének (6) bekezdésével összhangban benyújtott észrevételeket figyelembe vették az e határozatban előírt intézkedések meghatározása során.
English: The scientific data and other information included in the studies identified in the Annex to this Decision shall be restricted for use for the benefit of the applicant for a period of 5 years from the date of authorisation under the conditions laid down in Article 21(1) of Regulation (EC) No 1924/2006. Article 3
Hungarian: A tagállamokkal konzultáltak, ELFOGADTA EZT A HATÁROZATOT:
English: Provexis Natural Products Ltd, Thames Court, 1 Victoria Street, Windsor, Berkshire, SL4 1YB, United Kingdom Water-Soluble Tomato Concentrate (WSTC) I and II
Hungarian: Provexis Natural Products Ltd, Thames Court, 1 Victoria Street, Windsor, Berkshire, SL4 1YB, Egyesült Királyság
English: One of the objectives of the Regulation (EC) No 1924/2006 is to ensure that health claims are truthful, clear and reliable and useful to the consumer, and that wording and presentation are taken into account in that respect. Therefore, where the wording of claims used by the applicant has the same meaning for consumers as that of an authorised health claim, because they demonstrate the same relationship that exists between a food category, a food or one of its constituents and health, they should be subject to the same conditions of use, as indicated in the Annex to the present Decision.
Italian: Uno degli obiettivi del regolamento (CE) n. 1924/2006 è quello di garantire che le indicazioni sulla salute risultino veritiere, chiare, affidabili e utili ai consumatori, tenendo conto della loro formulazione e presentazione; quindi se la formulazione dell’indicazione utilizzata dal richiedente ha per i consumatori lo stesso significato di un’indicazione sulla salute autorizzata, in quanto dimostra lo stesso rapporto esistente tra una categoria di alimenti, un alimento o uno dei suoi costituenti e la salute, essa deve essere soggetta alle stesse condizioni d’uso, come indicato nell’allegato alla presente decisione.
English: Applicant — Address Nutrient, substance, food or food category
Latvian: Uzturviela, viela, pārtikas produkts vai pārtikas produktu kategorija
English: Zhang, F., Song, V., Neascu, M., Crosbie, L., Duncan, G., Horgan, G., de Roos, B. and O’Kennedy, N. Flow cytometric and proteomic studies examining the effects of WSTC on platelet function in vitro. Unpublished, 2007/2008.
Swedish: Zhang F, Song V, Neascu M, Crosbie L, Duncan G, Horgan G, de Roos B och O’Kennedy N, Flow cytometric and proteomic studies examining the effects of WSTC on platelet function in vitro, Ej publicerad, 2007/2008.